125 related articles for article (PubMed ID: 3105895)
1. Triggering of interferon gamma-primed macrophages by various known complement activators for nonspecific tumor cytotoxicity.
Leu RW; Herriott MJ
Cell Immunol; 1987 Apr; 106(1):114-21. PubMed ID: 3105895
[TBL] [Abstract][Full Text] [Related]
2. Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-gamma priming and triggering by various agents.
Herriott MJ; Leu RW
J Interferon Res; 1987 Apr; 7(2):165-71. PubMed ID: 3112246
[TBL] [Abstract][Full Text] [Related]
3. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
Leu RW; Rummage JA; Rahimi MB; Herriott MJ
Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
[TBL] [Abstract][Full Text] [Related]
5. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
6. Role of C5a in the induction of tumoricidal activity in C3H/HeJ (Lpsd) and C3H/OuJ (Lpsn) macrophages.
Hogan MM; Yancey KB; Vogel SN
J Leukoc Biol; 1989 Dec; 46(6):565-70. PubMed ID: 2509612
[TBL] [Abstract][Full Text] [Related]
7. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
Paulnock DM; Lambert LE
J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
[TBL] [Abstract][Full Text] [Related]
9. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
Falk LA; Hogan MM; Vogel SN
J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: LPS, immune complexes, and zymosan alone and in combination with interferon-gamma.
Zhou AQ; Herriott MJ; Leu RW
J Leukoc Biol; 1991 Nov; 50(5):453-63. PubMed ID: 1748841
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
13. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
14. Establishment of murine macrophage hybridoma clones capable of acquiring tumoricidal activity upon activation with recombinant interferon-gamma and lipopolysaccharide.
Kiyotaki C; Katagiri T; Tatsumi Y; Fujiwara H; Hamaoka T
J Cancer Res Clin Oncol; 1987; 113(4):383-6. PubMed ID: 3110175
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
16. Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma.
Celada A; Schreiber RD
J Immunol; 1986 Oct; 137(7):2373-9. PubMed ID: 3093574
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing.
Torres BA; Johnson HM
Biochem Biophys Res Commun; 1985 Aug; 131(1):395-401. PubMed ID: 3929779
[TBL] [Abstract][Full Text] [Related]
18. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions between IFN-gamma and IFN-beta in priming murine macrophages for tumor cell killing.
Pace JL
J Leukoc Biol; 1988 Dec; 44(6):514-20. PubMed ID: 3142957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
